Skip to content

Insider · CIK 0001952771

Calloway Nathaniel

Reports to the SEC for 2 companies · LAKEWAY,, TX

Transactions

13

Companies

2

Filings

9

CIK

0001952771

Forms 4 and 5

Insider transactions

13 trades
DateCompanyValue
2025-04-04ANEBAnebulo Pharmaceuticals, Inc. · Stock Option (right to buy)A Award—
2025-04-04ANEBAnebulo Pharmaceuticals, Inc. · Stock Option (right to buy)A Award—
2024-07-08LFCRLIFECORE BIOMEDICAL, INC. \DE\A Award—
2024-06-13ANEBAnebulo Pharmaceuticals, Inc. · Stock Option (right to buy)A Award—
2024-06-13ANEBAnebulo Pharmaceuticals, Inc. · Stock Option (right to buy)A Award—
2024-02-01LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion—
2024-02-01LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion—
2024-01-09LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion—
2024-01-09LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion—
2023-06-01LFCRLIFECORE BIOMEDICAL, INC. \DE\A Award—
2023-02-01LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitA Award—
2023-01-09LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitA Award—
2022-11-01ANEBAnebulo Pharmaceuticals, Inc. · Stock Option (right to buy)A Award—

Recent filings

9

Companies

2

Address

C/O ANEBULO PHARMACEUTICALS, INC. 1017 RANCH ROAD 620 SOUTH, STE. 107

LAKEWAY,, TX, 78734